| 17.04.2024 02:25:26 | |
|---|---|
| Cena | |
| 4.080,00 JPY | |
| Změna | -1,21% (-50,00) |
Základní údaje
| ISIN | JP3463000004 |
| Symbol | 4502 |
| Burza | Fukuoka Stock Exchange |
| Měna | JPY |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 37.870 EUR |
| Benchmark | NIKKEI 225 |
Tržní data
| Nákup (částka) | 4.020,00 JPY (100) |
| Prodej (částka) | 4.150,00 JPY (100) |
| Otevírací cena | 4.080,00 JPY |
| Max | 4.080,00 JPY |
| Min | 4.080,00 JPY |
| Závěrečná cena (předchozí den) | 4.130,00 JPY |
| Cena vážená obchodovaným objemem | 4.080,00 JPY |
| Objem (kusy) | 100 |
| Obchodovaný objem | 4.080,00 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 100 |
Futures a opce
| Související Futures | - |
| Související Opce | - |
PDF ke stažení
| Report společnosti: TAKEDA PHARMACEUTICAL CORP LTD. |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 26.04.2024 |
|
Global Equity Ratings |
|
| 03.04.2024 |
|
Global Equity Ratings |
|
| 13.03.2024 |
|
Global Equity Ratings |
|
| 22.02.2024 |
|
Global Equity Ratings |
|
| 14.02.2024 |
|
Global Equity Ratings |
|
Všechny burzy pro TAKEDA PHARMACEUTICAL CORP LTD.
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Vienna Stock Exchange | 30.04.2024 | 17:32 | 24,65 EUR | 0,00 | 2 |
| Tradegate | 30.04.2024 | 22:02 | 24,50 EUR | 0,03 | 9 |
| Tokyo Stock Exchange | 30.04.2024 | 08:00 | 4.153,00 JPY | 188,17 | 4.036 |
| Stuttgart | 30.04.2024 | 10:32 | 24,51 EUR | 0,00 | 4 |
| Sapporo Stock Exchange | 11.03.2024 | 01:53 | 4.300,00 JPY | 0,01 | 2 |
| Munich | 30.04.2024 | 08:03 | 24,61 EUR | 0,00 | 1 |
| London Stock Exchange | 26.03.2019 | 12:28 | 37,59 EUR | 0,00 | 1 |
| Hanover | 30.04.2024 | 08:44 | 24,61 EUR | 0,00 | 1 |
| Hamburg | 30.04.2024 | 08:12 | 24,59 EUR | 0,00 | 1 |
| Fukuoka Stock Exchange | 17.04.2024 | 02:25 | 4.080,00 JPY | 0,00 | 1 |
| Frankfurt | 30.04.2024 | 21:49 | 24,56 EUR | 0,01 | 2 |
| FINRA other OTC Issues | 26.04.2024 | 16:17 | 26,055 USD | 0,01 | 2 |
| Duesseldorf | 30.04.2024 | 19:30 | 24,53 EUR | 0,00 | 5 |
| Berlin | 30.04.2024 | 08:08 | 24,64 EUR | 0,00 | 1 |
| 17.04.2024 02:25:26 | |
|---|---|
| Cena | |
| 4.080,00 JPY | |
| Změna | -1,21% (-50,00) |
Základní údaje
| ISIN | JP3463000004 |
| Symbol | 4502 |
| Burza | Fukuoka Stock Exchange |
| Měna | JPY |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 37.870 EUR |
| Benchmark | NIKKEI 225 |
Tržní data
| Nákup (částka) | 4.020,00 JPY (100) |
| Prodej (částka) | 4.150,00 JPY (100) |
| Otevírací cena | 4.080,00 JPY |
| Max | 4.080,00 JPY |
| Min | 4.080,00 JPY |
| Závěrečná cena (předchozí den) | 4.130,00 JPY |
| Cena vážená obchodovaným objemem | 4.080,00 JPY |
| Objem (kusy) | 100 |
| Obchodovaný objem | 4.080,00 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 100 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | - | -5,23% | +9,83% |
| Výkonn. (abs.) | - | -225,00 | +365,00 |
| Beta | 0,30 | 0,42 | 0,46 |
| Volatilita | 75,39 | - | 96,92 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | - JPY (-) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 4.246,00 JPY (20) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 4.204,17 JPY (7) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | - JPY (-) |
| YTD Max| datum | - JPY (-) |
| YTD Min | datum | - JPY (-) |
| 52týdenní max. | datum | - JPY (-) |
| 52týdenní min. | datum | - JPY (-) |
Logo společnosti
Kontakty
| TAKEDA PHARMACEUTICAL CO. LTD. |
| - - |
| 4-1-1 Dosho-machi, Chuo-Ku - 540-8645 Osaka |
| Telefon:+81-6-6204-2111 |
| Fax:+81-6-6204-2880 |
| E-mail:- |
PDF ke stažení
| Report společnosti: TAKEDA PHARMACEUTICAL CORP LTD. | |
Profil společnosti
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
Členové představenstva
| Christophe Weber | Chairman of Managing Board |
| Andrew Plump | Member of Executive Committee |
| Costa Saroukos | Member of Executive Committee |
| Gabriele Ricci | Member of Executive Committee |
| Giles Platford | Member of Executive Committee |
| Julie Kim | Member of Executive Committee |
| Koki Sato | Member of Executive Committee |
| Lauren Duprey | Member of Executive Committee |
| Marcello Agosti | Member of Executive Committee |
| Milano Furuta | Member of Executive Committee |
| Mwana Lugogo | Member of Executive Committee |
| Ramona Sequeira | Member of Executive Committee |
| Takako Ohyabu | Member of Executive Committee |
| Teresa Bitetti | Member of Executive Committee |
| Thomas Wozniewski | Member of Executive Committee |
| Yoshihiro Nakagawa | Member of Executive Committee |
Představenstvo společnosti
| Masami Iijima | Chairman of Supervisory Board |
| Andrew Plump | Member of Supervisory Board |
| John Maraganore | Member of Supervisory Board |
| Olivier Jean Bohuon | Member of Supervisory Board |
| Steven Gillis | Member of Supervisory Board |
| Constantine Saroukos | Member of Supervisory Board |
| Emiko Higashi | Member of Supervisory Board |
| Ian Clark | Member of Supervisory Board |
| Jean-Luc Butel | Member of Supervisory Board |
| Kimberly Reed | Member of Supervisory Board |
| Koji Hatsukawa | Member of Supervisory Board |
| Michel Orsinger | Member of Supervisory Board |
| Miki Tsusaka | Member of Supervisory Board |
| Yoshiaki Fujimori | Member of Supervisory Board |